Some visit links earn us a commission.
Quick verdict
Henry Meds is the better pick for most patients on overall scoring. Henry built the cash-pay compounded GLP-1 category and still runs the cleanest version of it. Predictable bundled pricing and true month-to-month terms, though the semaglutide tiers moved behind signup in June 2026. Pivoted hard after the FDA shortage delisting and now leans on personalization-claim 503A pharmacies.
That said, Embla wins on specific dimensions. Embla is the closest thing the US market has to a Noom-meets-Calibrate hybrid that actually leans into the medication. Heavy behavioral coaching, branded-first prescribing, structured 12-month curriculum. Best for buyers who want the program to do half the work.
Side-by-side
| Henry Meds | Embla | |
|---|---|---|
| Starts from | $297/mo (incl. medication) | $249/mo (+ med separate) |
| Monthly cost gap | Henry Meds is $70/mo cheaper than Embla | |
| Lock-in | Month-to-month | 12-mo lock-in |
| Time to prescription | 2 days | 7 days |
| Consultation type | Asynchronous | Live |
| Affiliate network | Impact | Impact |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Henry Meds | Embla | |
|---|---|---|
| Pricing transparency | 8/10 | 4/10 |
| Cancellation terms | 9/10 | 7/10 |
| Onboarding experience | 8/10 | 6/10 |
| Medication options | 6/10 | 7/10 |
| Member reviews | 9/10 | 9.2/10 |
When to choose Henry Meds
Best for cheapest compounded
Buyers who want predictable flat-rate compounded semaglutide with no commitments and minimal friction.
Henry Meds wins on pricing transparency, cancellation terms, onboarding experience and runs $70/mo cheaper than Embla at the entry tier ($179 vs $249). Over a year that's $840 you keep. The caveat: Patients who want branded Wegovy or Zepbound through insurance, or who want a high-touch coaching program. Note also: Subject of ongoing scrutiny over personalization-claim compounding post-shortage delisting (FDA Feb 2025).
When to choose Embla
Best for structured behavior support
Patients who tried meds-only and bounced, and want a structured behavior program alongside GLP-1.
Embla wins on medication options, member reviews on the dimensional scoring. The caveat: Buyers who only want the script and find coaching content patronizing.
If cost is your main filter
Henry Meds is the cheaper monthly: $179 all-in vs $249 for Embla. That's $70 a month or $840a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $210 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Henry Meds (month-to-month) and Embla (12-mo lock-in) sit at different cancellation tiers. If you're first-time on a GLP-1 and unsure how you'll tolerate it, Henry Meds's easier cancellation is the safer trial.
FAQ
Is Henry Meds cheaper than Embla?
Can I switch from Henry Meds to Embla mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
